Monoarthritis and Oligoarthritis policy - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

Monoarthritis and Oligoarthritis policy

Last Updated: 26 July 2017

Body System: Musculoskeletal system

Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of anti-TNF (adalimumab, certolizumab, etanercept, golimumab, infliximab) by specialists only, for inflammatory monoarthritis or oligoarthritis as specified.